Discover
FLGT
Fulgent Genetics, Inc.
19.00
3 x 18.98
20 x 19.00
bid
ask
-
0.06
0.31%
2 @ 04:00 PM
19.00 +0.00 (0.00%)
| Ytd | -27.67% | |
| 1y | -7.81% |
18.98
day range
19.28
13.46
52 week range
31.04
| Open | 19.03 | Prev Close | 19.06 | Low | 18.98 | High | 19.28 | Mkt Cap | 539.61M |
| Vol | 0.00 | Avg Vol | 376.72K | EPS | 0.01 | P/E | 1900.00 | Forward P/E | -36.45 |
| Beta | 1.51 | Short Ratio | 2.87 | Inst. Own | 54.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 19.34 | 200-d Avg | 21.23 | 1yr Est | 27.67 |
| Income Statement | |||
| Total Revenue | 85.39M | ||
| Revenues (USD) | 85.39M | ||
| Cost of Revenue | 59.71M | ||
| Gross Profit | 25.68M | ||
| Operating Expenses | 61.75M | ||
| Research and Development Expense | 14.55M | ||
| Selling, General and Administrative Expense | 42.42M | ||
| Operating Income | -36.07M | ||
| Interest Expense | 59.00K | ||
| Income Tax Expense | 29.00K | ||
| Net Income | -29.53M | ||
| Net Income Common Stock | -29.53M | ||
| Net Income Common Stock (USD) | -29.53M | ||
| Consolidated Income | -29.72M | ||
| Net Income to Non-Controlling Interests | -189.00K | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -1.05 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -29.44M | ||
| Earning Before Interest & Taxes (USD) | -29.44M | ||
| Weighted Average Shares | 28.01M | ||
| Weighted Average Shares Diluted | 28.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.31M | ||
| Cash and Equivalents (USD) | 26.31M | ||
| Investments | 525.04M | ||
| Investments Current | 230.73M | ||
| Investments Non-Current | 294.32M | ||
| Trade and Non-Trade Receivables | 64.94M | ||
| Current Assets | 454.77M | ||
| Property, Plant & Equipment Net | 113.07M | ||
| Total Assets | 1.09B | ||
| Debt Current | 482.00K | ||
| Total Debt | 482.00K | ||
| Current Liabilities | 71.76M | ||
| Total Liabilities | 93.24M | ||
| Accumulated Retained Earnings (Deficit) | 475.60M | ||
| Accumulated Other Comprehensive Income | 1.92M | ||
| Shareholders Equity | 1.00B | ||
| Shareholders Equity (USD) | 1.00B | ||
| Assets Non-Current | 634.45M | ||
| Total Debt (USD) | 482.00K | ||
| Deferred Revenue | 3.40M | ||
| Deposit Liabilities | 28.81M | ||
| Goodwill and Intangible Assets | 134.63M | ||
| Liabilities Non-Current | 21.48M | ||
| Trade and Non-Trade Payables | 15.56M | ||
| Tax Assets | 110.57M | ||
| Tax Liabilities | 12.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.19M | ||
| Net Cash Flow from Financing | -24.22M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.91M | ||
| Capital Expenditure | -3.86M | ||
| Issuance (Purchase) of Equity Shares | -23.80M | ||
| Issuance (Repayment) of Debt Securities | -88.00K | ||
| Net Cash Flow from Investing | 50.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 54.66M | ||
| Net Cash Flow from Operations | -23.76M | ||
| Effect of Exchange Rate Changes on Cash | 88.00K | ||
| Share Based Compensation | 8.62M | ||